Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Change in Receivables (2020 - 2025)

PROCEPT BioRobotics has reported Change in Receivables over the past 6 years, most recently at -$2.2 million for Q4 2025.

  • Quarterly results put Change in Receivables at -$2.2 million for Q4 2025, down 115.04% from a year ago — trailing twelve months through Dec 2025 was $898000.0 (down 97.5% YoY), and the annual figure for FY2025 was $898000.0, down 97.5%.
  • Change in Receivables for Q4 2025 was -$2.2 million at PROCEPT BioRobotics, down from $4.4 million in the prior quarter.
  • Over the last five years, Change in Receivables for PRCT hit a ceiling of $14.8 million in Q4 2024 and a floor of -$3.9 million in Q1 2025.
  • Median Change in Receivables over the past 5 years was $2.6 million (2021), compared with a mean of $4.2 million.
  • Biggest five-year swings in Change in Receivables: tumbled 766.97% in 2021 and later soared 631.15% in 2024.
  • PROCEPT BioRobotics' Change in Receivables stood at -$1.9 million in 2021, then skyrocketed by 228.78% to $2.4 million in 2022, then soared by 465.08% to $13.8 million in 2023, then grew by 7.84% to $14.8 million in 2024, then plummeted by 115.04% to -$2.2 million in 2025.
  • The last three reported values for Change in Receivables were -$2.2 million (Q4 2025), $4.4 million (Q3 2025), and $2.7 million (Q2 2025) per Business Quant data.